Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 25/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and Rifampin treatment group.

Abundance in Group 1: increased abundance in R (Rifampin)

NCBI	Quality Control	Links
Erysipelotrichaceae
Caloramator
Enterorhabdus
Ethanoligenens
Turicibacter
Thomasclavelia
Arthrobacter
Guggenheimella
Gordonibacter
Pseudobacteroides
Blautia
Marvinbryantia
Christensenella
Anaerostipes
Eisenbergiella
Anaerosporobacter
Eubacterium
Hydrogenoanaerobacterium
Intestinimonas
Pseudoflavonifractor
Roseburia
Acetatifactor
Dysgonomonas
Flavonifractor
Mucispirillum
Erysipelothrix
Oscillibacter
Coprobacter
Tannerella
Lachnospiraceae
Bacteroides

Revision editor(s): KateRasheed